United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Cambridge Life Sciences Cluster Continues To Attract Investment

The Cambridge life sciences cluster demonstrates remarkable resilience with a significant surge in equity fundraising during the first half of 2026. Investment activity has increased not only in total capital raised but also in the number of companies successfully securing funding, reflecting deep confidence in the region's innovation ecosystem. Infrastructure developments including expanded research hubs and improved transport connectivity signal a flourishing sector poised for continued growth.

United Kingdom Healthcare

MC

Marks & Clerk

The Business Of Beauty: From Luxury To Longevity With Lindy Firstenberg (Podcast)

This week, Kate sits down with Lindy Firstenberg, Co-Lead of the Beauty, Health & Wellness Practice at AlixPartners. From helping launch Louis Vuitton Fragrance to advising founders, retailers, investors, and global brands, Lindy has spent her career at the forefront of the industry's biggest shifts. Now, she's stepping into entrepreneurship herself, co-founding a science-backed scar repair company built around breakthrough biotechnology.

United Kingdom Consumer

A

AlixPartners

Patents And The Birth Of Materials Informatics

From Victorian engineering to modern AI, explore how David Kirkaldy's 1865 Universal Testing Machine and his pioneering data-driven approach laid the groundwork for today's materials informatics revolution. Discover how patent protection has evolved to protect innovations in computational materials science and machine learning applications.

United Kingdom IP

KL

Keltie LLP

Sharper, Faster, Smarter: Quantum Sensing In Healthcare

Quantum sensing technology is revolutionizing healthcare diagnostics and treatment, with innovations ranging from brain function assessment devices to cancer detection platforms. As the quantum industry transitions from concept to reality, patent protection and strategic intellectual property management are becoming crucial for companies developing these transformative medical technologies.

United Kingdom IP

KL

Keltie LLP

Excipient Or Active Ingredient? Look To The Marketing Authorisation…

United Kingdom IP

HL

HGF Ltd

Life Sciences Patents Monthly Roundup—June 2026

AO

A&O Shearman

Innovation In FemTech

United Kingdom IP

CR

Carpmaels & Ransford LLP

UK Election 24 - AI In Life Sciences – What Changes To The Regulatory And Innovation Landscape Could The UK Elections Bring?

United Kingdom Technology

KL

Herbert Smith Freehills Kramer LLP

Injectable Cancer Immunotherapies: New Innovations Shortening Treatment Times And Reducing Costs

United Kingdom Healthcare

B

Boult Wade Tennant

Combination Therapies: IP Considerations For Synergistic Biologic Products

United Kingdom IP

PC

Potter Clarkson

Perfect Storm - Four Drivers Behind The MRNA Litigation Wave

United Kingdom IP

PC

Potter Clarkson

Agritech Thymes: EU Adopts New NGT Regulation: Key IP Takeaways For The Agritech Sector

United Kingdom IP

HL

HGF Ltd

Beyond PARP – What’s Next For DNA Damage Response-targeted Therapies?

United Kingdom IP

JA

J A Kemp LLP

European Parliament Approves NGT Regulation

United Kingdom IP

JA

J A Kemp LLP

What Are The Practical Implications Of The Reform Of EU Design Law Coming Into Force On 1st July 2026? (Podcast)

European Union IP

HL

HGF Ltd

FinTech Global FS Regulatory Round-up - W/e 5 June 2026

Worldwide Technology

KL

Herbert Smith Freehills Kramer LLP

London X China Podcast Series - Episode 7: Trends In Global Pharma M&A

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Navigating The Semiconductor-auto Nexus In The Age Of AI

Worldwide Strategy

A

AlixPartners

Age Discrimination At Work: Your Rights Under Employment Law (10 June 2026) (Video)

United Kingdom Employment

DL

Duncan Lewis & Co Solicitors

AI-assisted Lung Cancer Diagnosis To Be Rolled Out Across NHS By 2029

The Royal Surrey NHS Foundation Trust has begun deploying artificial intelligence tools to analyse chest X-ray results for lung cancer diagnoses, with the UK government committing to roll out these AI-powered systems across all NHS trusts in England by 2029. The technology acts as a "second pair of eyes" for radiologists, prioritising X-rays showing potential danger signs for expedited human review.

United Kingdom Technology

MC

Marks & Clerk

Patent Landscape And Freedom-to-operate Analysis For RNA-based Therapies: Identifying IP Risks Early

RNA-based therapies represent a rapidly evolving frontier in biotechnology, but the increasingly crowded innovation space presents complex intellectual property challenges that many developers overlook until it's too late.

United Kingdom IP

PC

Potter Clarkson

Light Sleepers: Optogenetic Stimulation Offers Sleep-like Benefits

Researchers at the University of Wisconsin-Madison have discovered that optogenetic stimulation can replicate certain benefits of sleep in awake mice, potentially offering memory consolidation advantages without requiring actual sleep.

United Kingdom Healthcare

MC

Marks & Clerk

Creating An Effective IP Strategy For CAR-T

The key reason an IP strategy for CAR-T is so essential for companies operating in this space is that it will protect your innovation and allow you to best manage third-party rights.

United Kingdom IP

PC

Potter Clarkson

When Is A Synbio Company A Gene Therapy Company?

United Kingdom Healthcare

PC

Potter Clarkson

Drug Repurposing In The Age Of AI: Lessons From COVID-19 And The Future Of Second Medical Use Innovation

United Kingdom IP

PC

Potter Clarkson

Launching “At Risk” In The UK: Why Recent Patent Injunction Decisions Matter For MedTech And Digital Health Companies

United Kingdom IP

MC

Marks & Clerk

UK MHRA Consults On A New Regulatory Framework For Rare Disease Therapies

United Kingdom Healthcare

AP

Arnold & Porter

MHRA Launches Consultation On Modernising The Definition Of Gene Therapy Medicinal Products

United Kingdom Healthcare

AP

Arnold & Porter

Battery Recycling And Reuse Technologies Drive Patent Growth

M

Murgitroyd

London X China Podcast Series - Episode 7: Trends In Global Pharma M&A

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

UPC Court Of Appeal Endorses EPO Approach To Inventive Step For Computer-Implemented Inventions

United Kingdom IP

JA

J A Kemp LLP

New PMAC Model Clauses: Position Your IP Agreements For The UPC Era

United Kingdom IP

GW

Gowling WLG

Draft UK Medical Device Amending Regulations: Key Proposals And MHRA Call For Evidence

Worldwide Healthcare

AP

Arnold & Porter

London X China Podcast Series - Episode 7: Trends In Global Pharma M&A

This podcast focuses on the pharmaceutical industry and, in particular, M&A activity in the sector and the recent surge in licensing deals involving Chinese biotechs.

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

UPC Court Of Appeal Endorses EPO Approach To Inventive Step For Computer-Implemented Inventions

In Abbott v Sinocare, UPC_CoA_901/2025, 17 April 2026, the UPC Court of Appeal endorsed the EPO approach to assessing inventive step for computer-implemented inventions.

United Kingdom IP

JA

J A Kemp LLP

New PMAC Model Clauses: Position Your IP Agreements For The UPC Era

The Patent Mediation and Arbitration Centre (PMAC), the Unified Patent Court’s (UPC's) specialist alternative dispute resolution (ADR) body, has published model ADR clauses and submission agreements...

United Kingdom IP

GW

Gowling WLG

Draft UK Medical Device Amending Regulations: Key Proposals And MHRA Call For Evidence

On 11 May 2026, the Medicines and Healthcare products Regulatory Agency (“MHRA”) opened a call for evidence on proposed changes to pre-market medical device and in vitro diagnostic medical device (“IVD”)...

Worldwide Healthcare

AP

Arnold & Porter

Impact Beyond Orbcit - The Breadth Of Value Of Space Technology

United Kingdom IP

MC

Marks & Clerk

Virtual And Digital Health Digest – April 2026

Welcome to the latest installment of Arnold & Porter’s Virtual and Digital Health Digest. This digest covers key virtual and digital health regulatory and public policy developments...

United Kingdom Healthcare

AP

Arnold & Porter

Navigating IVD Regulation In Clinical Trials: A Comparative EU And UK Guide

Assays used in clinical trials vary widely in complexity and regulatory status.. They may be fully developed and marketed as in vitro diagnostic medical devices (IVDs), including companion diagnostics (CDx)...

European Union Healthcare

AP

Arnold & Porter

The Never-ending Licence That Ended: Court Of Appeal Clarifies Licence Termination Rights

The Court of Appeal has delivered a notable judgment on the interpretation of term and termination provisions in intellectual property licence agreements.

United Kingdom IP

GW

Gowling WLG

Stacked: The New Shape Of The Supplement Industry

You wake up, drink your AG1, chew your multivitamin gummy, and swallow your BPC-157 and TB-4 oral peptide supplements.

United Kingdom Healthcare

A

AlixPartners

EU General Court: Technical Vaccine Data Does Not Have To Be Disclosed On Request

United Kingdom Healthcare

A

Altius

Pharma: Key UK Legal Developments From 2025

Worldwide Healthcare

KL

Herbert Smith Freehills Kramer LLP

Listing And Prospectus Regime – FCA Consultation On Miscellaneous Amendments

United Kingdom Commercial

KL

Herbert Smith Freehills Kramer LLP

Snapshot: Key European Pharma Regulatory, IP And Competition Developments From 2025 For The Pharmaceutical Sector

European Union Healthcare

KL

Herbert Smith Freehills Kramer LLP

Provisional Text Of The Political Agreement On The Reform To The EU Regulatory Framework For Medicinal Products Is Published

United Kingdom Healthcare

AP

Arnold & Porter

'WHOOP WHOOP' - A Wearable Focused On Women's Health

United Kingdom Healthcare

MC

Marks & Clerk

Virtual And Digital Health Digest – February 2026

United Kingdom Healthcare

AP

Arnold & Porter

Changes To UK Clinical Trials Regulations Take Effect April 28, 2026. New Versions Of UK Model Clinical Trial Agreement Forms Pending

United Kingdom Healthcare

CM

Crowell & Moring LLP

New Injectable Bandages To Reduce Bleed Time By Almost 70%

United Kingdom IP

MC

Marks & Clerk

Five Governance Essentials To Reduce False Claims Act Risk

United Kingdom Commercial

A

AlixPartners

An IP Guide To Biosimilars

United Kingdom IP

B

Boult Wade Tennant

UK Government Sets Out 2026 Branded Medicines Statutory Scheme Repayment Rate

United Kingdom Healthcare

AP

Arnold & Porter

Healthcare & Life Sciences – AI Readiness & Integration Questionnaire

United Kingdom Healthcare

AG

Addleshaw Goddard

UK PMCPA Releases New Guidance On Package Deals: Key Takeaways For Industry

United Kingdom Healthcare

AP

Arnold & Porter

UK's Data (Use And Access) Act: What Life Sciences Companies Need To Know

United Kingdom Healthcare

AP

Arnold & Porter

See more

Latest Videos

See more

Working For And With The European Medicines Agency (EMA) (Video)

AP

Arnold & Porter

Legally Vocal: Patrick Duxbury On His COVID-19 Vaccine Work And 20-Year Career In Life Sciences (Video)

GW

Gowling WLG

Claim One – #01 EPO Oral Proceedings (Video)

H

HLK

Using Patents To Raise Finance - Dehns And Green Biologics (Video)

D

Dehns

Measuring The Return From Pharmaceutical Innovation 2012 (Video Content)

D

Deloitte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More